European Biotech Acquisition Corp. Units

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EBACU and buy or sell other stocks, ETFs, and their options commission-free!

About EBACU

European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland. 

CEO
Eduardo Bravo Fernández de Araoz, MBA
CEOEduardo Bravo Fernández de Araoz, MBA
Employees
49
Employees49
Headquarters
Lausanne, Vaud
HeadquartersLausanne, Vaud
Founded
2021
Founded2021
Employees
49
Employees49

EBACU Key Statistics

Market cap
591.84M
Market cap591.84M
Price-Earnings ratio
540.67
Price-Earnings ratio540.67
Dividend yield
Dividend yield
Average volume
4.69K
Average volume4.69K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.27
52 Week high$13.27
52 Week low
$8.98
52 Week low$8.98

Stock Snapshot

With a market cap of 591.84M, European Biotech Acquisition Corp. Units(EBACU) trades at $11.30. The stock has a price-to-earnings ratio of 540.67.

European Biotech Acquisition Corp. Units(EBACU) stock opened on 2025-12-09 at —. The price climbed to — and dipped to —.

European Biotech Acquisition Corp. Units(EBACU) shares are trading with a volume of 0, against a daily average of 4.69K.

During the past year, European Biotech Acquisition Corp. Units(EBACU) stock moved between $8.98 at its lowest and $13.27 at its peak.

During the past year, European Biotech Acquisition Corp. Units(EBACU) stock moved between $8.98 at its lowest and $13.27 at its peak.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.